Design, synthesis, in vitro and in silico characterization of new 2-quinolone-L-alaninate-1,2,3-triazoles as novel antimicrobial agents

Oussama Moussaoui*, Bhadane Rajendra, Riham Sghyar, Janez Ilaš, El Mestafa El Hadrami, Said Chakroune, Outi Salo-Ahen*

*Tämän työn vastaava kirjoittaja

Tutkimustuotos: LehtiartikkeliArtikkeliTieteellinenvertaisarvioitu

12 Lataukset (Pure)

Abstrakti

Due to the ever-increasing antimicrobial resistance there is an urgent need to continuously design and develop novel antimicrobial agents. Inspired by the broad antibacterial activities of various heterocyclic compounds such as 2-quinolone derivatives, we designed and synthesized new methyl-(2-oxo-1,2-dihydroquinolin-4-yl)-L-alaninate-1,2,3-triazole derivatives via 1,3-dipolar cycloaddition reaction of 1-propargyl-2-quinolone-L-alaninate with appropriate azide groups. The synthesized compounds were obtained in good yield ranging from 75 to 80 %. The chemical structures of these novel hybrid molecules were determined by spectroscopic methods and the antimicrobial activity of the compounds was investigated against both bacterial and fungal strains. The tested compounds showed significant antimicrobial activity and weak to moderate antifungal activity. Despite the evident similarity of the quinolone moiety of our compounds with fluoroquinolones, our compounds do not function by inhibiting DNA gyrase. Computational characterization of the compounds shows that they have attractive physicochemical and pharmacokinetic properties and could serve as templates for developing potential antimicrobial agents for clinical use.
AlkuperäiskieliEnglanti
JulkaisuChemMedChem
DOI - pysyväislinkit
TilaJulkaistu - 2022
OKM-julkaisutyyppiA1 Julkaistu artikkeli, soviteltu

Sormenjälki

Sukella tutkimusaiheisiin 'Design, synthesis, in vitro and in silico characterization of new 2-quinolone-L-alaninate-1,2,3-triazoles as novel antimicrobial agents'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.

Viittausmuodot